Luminate Medical Revenue and Competitors
Estimated Revenue & Valuation
- Luminate Medical's estimated annual revenue is currently $16.4M per year.
- Luminate Medical's estimated revenue per employee is $342,000
- Luminate Medical's total funding is $25M.
Employee Data
- Luminate Medical has 48 Employees.
- Luminate Medical grew their employee count by 45% last year.
Luminate Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | VP Clinical Operation | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
4 | Clinical Trial Device Specialist | Reveal Email/Phone |
5 | Principal Research & Development Engineer | Reveal Email/Phone |
6 | Research And Development Engineer | Reveal Email/Phone |
7 | Senior R&D Technician | Reveal Email/Phone |
8 | Graduate R&D Engineer | Reveal Email/Phone |
9 | Senior Design Engineer | Reveal Email/Phone |
10 | Graduate Manufacturing Engineer | Reveal Email/Phone |
Luminate Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.4M | 80 | 18% | N/A | N/A |
#2 | $228.4M | 480 | 5% | N/A | N/A |
#3 | $16.4M | 48 | 45% | $24.9M | N/A |
What Is Luminate Medical?
Luminate Medical is a healthcare technology company that builds devices to prevent and control the side effects of cancer treatment. Based in Galway, Ireland, Luminate is pioneering the development of Lily, a device to prevent chemotherapy induced hair loss in a comfortable and portable way, and Lilac, the world's first preventative treatment for peripheral neuropathy. Luminate is a VC-backed startup funded by Y Combinator (S21) with multiple successful grant and investment rounds to date.
keywords:N/A$25M
Total Funding
48
Number of Employees
$16.4M
Revenue (est)
45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.3M | 49 | 48% | N/A |
#2 | $12.6M | 52 | 33% | N/A |
#3 | $8M | 57 | 24% | N/A |
#4 | $5.3M | 58 | 0% | N/A |
#5 | $9.1M | 59 | 9% | N/A |